In conclusion, our findings identified a new molecular pattern in patients affected by HCC where elevated levels of SerpinB3 associated with p66shc downregulation showed markedly better survival, likely because tumor cells were more prone to die by necroptosis. Here, SERPINB3 is linked to hepatocellular carcinoma.